These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 38484189)
1. A temporal developmental map separates human NK cells from noncytotoxic ILCs through clonal and single-cell analysis. Vo DN; Yuan O; Kanaya M; Telliam-Dushime G; Li H; Kotova O; Caglar E; Honnens de Lichtenberg K; Rahman SH; Soneji S; Scheding S; Bryder D; Malmberg KJ; Sitnicka E Blood Adv; 2024 Jun; 8(11):2933-2951. PubMed ID: 38484189 [TBL] [Abstract][Full Text] [Related]
2. CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway. Chen L; Youssef Y; Robinson C; Ernst GF; Carson MY; Young KA; Scoville SD; Zhang X; Harris R; Sekhri P; Mansour AG; Chan WK; Nalin AP; Mao HC; Hughes T; Mace EM; Pan Y; Rustagi N; Chatterjee SS; Gunaratne PH; Behbehani GK; Mundy-Bosse BL; Caligiuri MA; Freud AG Immunity; 2018 Sep; 49(3):464-476.e4. PubMed ID: 30193847 [TBL] [Abstract][Full Text] [Related]
3. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease. Gelmez MY; Cinar S; Cetin EA; Ozcit-Gürel G; Babuna-Kobaner G; Erdugan M; Gul A; Akdag-Kose A; Deniz G Immunol Lett; 2021 Jul; 235():1-8. PubMed ID: 33901541 [TBL] [Abstract][Full Text] [Related]
4. Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells. Ahn YO; Blazar BR; Miller JS; Verneris MR Blood; 2013 Mar; 121(12):2234-43. PubMed ID: 23327921 [TBL] [Abstract][Full Text] [Related]
5. Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor. Montaldo E; Vitale C; Cottalasso F; Conte R; Glatzer T; Ambrosini P; Moretta L; Mingari MC Blood; 2012 Apr; 119(17):3987-96. PubMed ID: 22403260 [TBL] [Abstract][Full Text] [Related]
12. Single-cell RNA-seq identifies a PD-1 Yu Y; Tsang JC; Wang C; Clare S; Wang J; Chen X; Brandt C; Kane L; Campos LS; Lu L; Belz GT; McKenzie AN; Teichmann SA; Dougan G; Liu P Nature; 2016 Nov; 539(7627):102-106. PubMed ID: 27749818 [TBL] [Abstract][Full Text] [Related]
13. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. Kyoizumi S; Kubo Y; Kajimura J; Yoshida K; Hayashi T; Nakachi K; Moore MA; van den Brink MRM; Kusunoki Y J Immunol; 2017 Oct; 199(8):2777-2793. PubMed ID: 28893953 [TBL] [Abstract][Full Text] [Related]
14. Group 1 ILCs: Heterogeneity, plasticity, and transcriptional regulation. Sudan R; Gilfillan S; Colonna M Immunol Rev; 2024 May; 323(1):107-117. PubMed ID: 38563448 [TBL] [Abstract][Full Text] [Related]
15. Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and Cancer. Calvi M; Di Vito C; Frigo A; Trabanelli S; Jandus C; Mavilio D Front Immunol; 2022; 13():914266. PubMed ID: 35720280 [TBL] [Abstract][Full Text] [Related]
16. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Grzywacz B; Kataria N; Sikora M; Oostendorp RA; Dzierzak EA; Blazar BR; Miller JS; Verneris MR Blood; 2006 Dec; 108(12):3824-33. PubMed ID: 16902150 [TBL] [Abstract][Full Text] [Related]
17. Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. Li N; van Unen V; Höllt T; Thompson A; van Bergen J; Pezzotti N; Eisemann E; Vilanova A; Chuva de Sousa Lopes SM; Lelieveldt BPF; Koning F J Exp Med; 2018 May; 215(5):1383-1396. PubMed ID: 29511064 [TBL] [Abstract][Full Text] [Related]
18. Development of human natural killer cells and other innate lymphoid cells. Montaldo E; Vacca P; Moretta L; Mingari MC Semin Immunol; 2014 Apr; 26(2):107-13. PubMed ID: 24559836 [TBL] [Abstract][Full Text] [Related]
20. Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy. Rethacker L; Roelens M; Bejar C; Maubec E; Moins-Teisserenc H; Caignard A Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33810032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]